CRISPRlike

CRISPRlike refers to a family of genome editing technologies that are conceptually and structurally modeled after CRISPR-Cas systems. The term describes programmable, site-specific methods that employ an RNA-guided nuclease or a similar effector to recognize a target sequence and introduce a modification. While CRISPR-Cas9 is the most widely known example, CRISPRlike platforms encompass a broader range of nucleases, guide designs, and target types, including DNA and RNA editing possibilities.

Mechanism: In typical CRISPRlike systems, a programmable guide molecule directs an effector protein to a complementary genetic sequence. Binding is followed by a nuclease cut, or by a base- or prime-editing modality, enabling precise alterations via cellular repair pathways. Some CRISPRlike approaches can target RNA without permanently altering the genome, enabling transient changes.

Features: Key considerations include guide design, nuclease compatibility, and PAM or analogous sequence requirements that constrain targetable sites. Delivery methods vary and include viral vectors, lipid nanoparticles, or physical methods. Outcomes range from gene disruption to precise substitutions or insertions. Off-target activity and immunogenicity remain important safety considerations.

Applications and status: Research uses include functional genomics, disease modeling, and development of gene therapies and agricultural traits. The field is rapidly evolving, with parallel advances in accuracy, efficiency, and delivery. Ethical and regulatory issues center on safety, potential germline effects, and equitable access.

See also: CRISPR, gene editing, base editing, prime editing, RNA editing.